kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - Други антинеопластични средства - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
valsagen 40 mg capsules, hard
generics /uk/ limited - Валсартан - 40 mg capsules, hard
valsagen 80 mg capsules, hard
generics /uk/ limited - Валсартан - 80 mg capsules, hard
valsagen 160 mg capsules, hard
generics /uk/ limited - Валсартан - 160 mg capsules, hard
candesagen 4 mg tablets
generics(uk) ltd - 4 mg tablets
candesagen 8 mg tablets
generics(uk) ltd - 8 mg tablets
candesagen 16 mg tablets
generics(uk) ltd - 16 mg tablets
candesagen 32 mg tablets
generics(uk) ltd - 32 mg tablets
neo-angin sage 1.20 mg/0.60 mg/5.90 mg lozenges
divapharma gmbh - различни - 1.20 mg/0.60 mg/5.90 mg lozenges